Raymond James & Associates’s Atreca, Inc. Class A Common Stock BCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-77,500
Closed -$20.2K 3980
2023
Q3
$20.2K Hold
77,500
﹤0.01% 3735
2023
Q2
$76K Sell
77,500
-24
-0% -$25 ﹤0.01% 3672
2023
Q1
$88.4K Hold
77,524
﹤0.01% 3672
2022
Q4
$62.1K Sell
77,524
-6,250
-7% -$7.95K ﹤0.01% 3699
2022
Q3
$132K Hold
83,774
﹤0.01% 3554
2022
Q2
$150K Buy
83,774
+21,000
+33% +$43.9K ﹤0.01% 3590
2022
Q1
$199K Buy
+62,774
New +$152K ﹤0.01% 3670

Other funds holding BCEL

Raymond James & Associates's BCEL Position: Q4 2023 in Review

Raymond James & Associates sold out of Atreca, Inc. Class A Common Stock (BCEL) in Q4 2023, closing a stake of 77,500 shares — an estimated $20.2K sold.

Raymond James & Associates first reported a position in BCEL in Q1 2022 and held it in 7 quarters. The position peaked at $199K in Q1 2022. 43 funds tracked by Wall St. Rank hold BCEL as of Q4 2023.

  • Raymond James & Associates reported no remaining Atreca, Inc. Class A Common Stock position as of Q4 2023 after selling out during the quarter.
  • Raymond James & Associates sold 77,500 Atreca, Inc. Class A Common Stock shares in Q4 2023, an estimated $20.2K.
  • Raymond James & Associates first reported a position in Atreca, Inc. Class A Common Stock in Q1 2022 and held it in 7 quarters.
  • Raymond James & Associates's Atreca, Inc. Class A Common Stock position peaked at $199K in Q1 2022.
  • 43 funds tracked by Wall St. Rank held Atreca, Inc. Class A Common Stock as of Q4 2023.

Based on Raymond James & Associates's 13F filing for Q4 2023, filed 16 Jan 2024.